Medpharm Limited
03783386
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 08/12/2018
PRIVATE EQUITY
AMERICAN · UNITED STATES · Age 65
Also on 1 other board
director · Since 01/04/2025
DIRECTOR
AMERICAN · UNITED STATES · Age 59
Also on 1 other board
Persons with Significant Control
Medpharm Holdco Limited
Unit 3 Chancellor Court, 50 Occam Road, Guildford, GU2 7AB
Reg: 11234758 · Companies House · Private Limited Company
Notified 15/03/2018
Former PSCs
Dr Andrew Gordon Muddle
Ceased 15/03/2018
Charges2 outstanding
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
WELLS FARGO BANK, NATIONAL ASSOCIATION
WELLS FARGO BANK, NATIONAL ASSOCIATION
WELLS FARGO BANK, NATIONAL ASSOCIATION
WELLS FARGO BANK, NATIONAL ASSOCIATION
BANK OF SCOTLAND PLC
UNIVERSITY OF SURREY
ALDERMORE BANK PLC
UNIVERSITY OF SURREY
UNIVERSITY OF SURREY
THE GOVERNOR AND COMPANY OF THE BANK OF SCOTLAND
CompanyRankvs 1651+ SIC 72110 peers27
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going concern are d
Key FinancialsYear ending 31/12/2024
Turnover
£9.0M
Annual revenue
Net Worth
-£32.5M
Balance sheet strength
Cash
£217k
Cash in the bank
Profit Before Tax
-£26.1M
Bottom line earnings
Net Current Assets
-£34.8M
Working capital
Current Assets
£6.7M
Current Liabilities
£41.5M
Fixed Assets
£2.3M
Debtors
£6.4M
Cost of Sales
£9.9M
Gross Profit
-£837k
Admin Expenses
£4.9M
Operating Profit
-£5.1M
Profit After Tax
-£26.2M
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.16 | -£26.2M |
| 2023 | 0.34 | — |
Derived from filed accounts. Not audited figures.